Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 3/20 | 0.74 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.69 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.66 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.66 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.63 |
| ▸ | FASN | P49327 | 3/20 | 0.63 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.63 |
| ▸ | IDH1 | O75874 | 2/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | SI | P14410 | 2/20 | 0.63 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.63 |
| ▸ | PGAM1 | P18669 | 2/20 | 0.63 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.63 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.63 |
| ▸ | TTR | P02766 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.63 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.63 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Licoflavonol SCHEMBL29392785 | 0.91 | ABCG2 (0.82) | MGAMABCG2ABCB1PTPN1PDE4D | |
| Licoflavonol SCHEMBL8050093 | 0.91 | ABCG2 (0.82) | MGAMABCG2ABCB1PTPN1PDE4D | |
| SCHEMBL26621022 | 0.90 | MGAM (0.72) | MGAMABCG2PTPN1PDE4DCYP19A1 | |
| Gancaonin P SCHEMBL1170933 | 0.87 | MGAM (0.76) | MGAMABCG2ABCB1PTPN1PDE4D | |
| SCHEMBL24075660 | 0.85 | MGAM (0.80) | MGAMABCG2PTPN1PDE4DCYP19A1 | |
| SCHEMBL29833229 | 0.85 | MGAM (0.80) | MGAMABCG2PTPN1PDE4DCYP19A1 | |
| SCHEMBL26621024 | 0.85 | MGAM (0.73) | MGAMABCG2PTPN1PDE4DCYP19A1 | |
| Broussonol E SCHEMBL30341880 | 0.85 | MGAM (1.00) | MGAMABCG2PTPN1PDE4DCYP19A1 | |
| Broussonol E SCHEMBL25404646 | 0.85 | MGAM (1.00) | MGAMABCG2PTPN1PDE4DCYP19A1 | |
| SCHEMBL27625154 | 0.85 | ABCG2 (0.67) | MGAMABCG2PTPN1PDE4DCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2003968-A2 | COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PRODUCTS, SO INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF | Leschot Sanhueza, Andres Antonio (CL) | 2008-12-24 | — | — | EP | disclosed |
| US-20070232495-A1 | Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof | NAPPA ALVARO O | 2007-10-04 | — | — | US | disclosed |
| WO-2007110801-A2 | COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PORDUCTS, INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF | LESCHOT SANHUEZA ANDRES ANTONI (CL) | 2007-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232495-A1 | Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof | C5, PNN, NQO1 | MGAM 519/4885ABCG2 3004/4885ABCB1 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.